Analysis of patients with malignant and paramalignant pleural effusion.

被引:0
|
作者
Cakmak, Muharrem [1 ]
Durkan, Atilla [1 ]
机构
[1] Gazi Yasargil Educ & Res Hosp, Thorac Surg Clin, Diyarbakir, Turkey
来源
BIOMEDICAL RESEARCH-INDIA | 2017年 / 28卷 / 05期
关键词
Malignant; Paramalignant; Effusion;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
While the malignant cells in the fluid are available in malignant pleural effusions (MPE), in paramalignant pleural effusions (PMPE), the malignant cells do not exist. We aimed to compare the results of patients with MPE and PMPE. Materials and methods: 134 patients (MPE: 106 PMPE: 28) were analysed retrospectively. Patients were divided into 2 groups as MPE, and PMPE. Results were analysed. P<0.05 was considered significant. Results: 65 of the patients with MPE were malignant mesothelioma (MM), while 41 of them were pleural metastasis. 28 of patients were PMPE. Male gender, right localization and exudative feature were found to be significant for patients with MPE. On the other hand, pleural effusion having exudative feature was significant for patients with PMPE. MM, chondrosarcoma, lung and liver cancer were found to be more effective in the formation MPE. Mortality was higher in patients with MPE (n=4). Tube thoracostomy was found as primary treatment method in treatment of patients with MPE. Conclusion: MPE and PMPE are caused by underlying malignant diseases. The mortality rate is higher in patients with pleural metastatic. Tube thoracostomy and pleurodesis are the primary treatment methods.
引用
收藏
页码:2226 / 2229
页数:4
相关论文
共 50 条
  • [41] Phase I study of intra-pleural administration of GL-ONC1, an oncolytic vaccinia virus, in patients with malignant pleural effusion.
    Krug, Lee M.
    Zauderer, Marjorie Glass
    Adusumili, Prasad S.
    Mcgee, Erin
    Sepkowitz, Kent
    Klang, Mark
    Yu, Yong A.
    Scigalla, Paul
    Rusch, Valerie W.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [42] Intracavitary IL-2 immunotherapy in malignant pleural effusion. Phase II study.
    Ferrari, VD
    Tassi, GF
    Marchetti, P
    Trignani, M
    Valcamonico, F
    Marini, G
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 644S - 644S
  • [43] Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study
    Stefani, Alessandro
    Natali, Pamela
    Casali, Christian
    Morandi, Uliano
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2006, 30 (06) : 827 - 832
  • [44] Carcinoembryonic antigen, C-reactive protein and lactate dehydrogenase measurement in pleural fluid of patients with malignant pleural effusion. A case-control study with multivariate analysis
    Lumachi, F.
    Ubiali, P.
    Tozzoli, R.
    Del Conte, A.
    Ermani, M.
    Basso, S. M. M.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S179 - S180
  • [45] Cytology, chest computed and positron emission tomography correlations in lung cancer malignant pleural effusion.
    Brun, Clement
    Gay, Pierre
    Cottier, Michelle
    Karpathiou, Georgia
    Barral, Fabrice-Guy
    Vergnon, Jean-Michel
    Froudarakis, Marios E.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [46] Cell clusters in pleural effusion. Not always bad news
    De La Puente Molina, E. Martinez
    Lopez-Urrutia Fernandez, A.
    Perez Garay, R.
    Blazquez Urtizberea, U.
    CLINICA CHIMICA ACTA, 2024, 558
  • [47] Limitations of Computerised Tomography (CT) in the Investigation of Pleural Effusion.
    Bakere, H.
    Norris, T.
    Gillgan, L.
    Duncan, P.
    Berrisford, R.
    Froeschle, P.
    Patel, B. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [48] Phenytoin Induced Late Onset Fulminant Pleural Effusion.
    Ahmad, S.
    Kamal, S. A.
    Asthari, M.
    Brea, C.
    Lawrence, D.
    Vela, A.
    Dave, D.
    Haralambou, G.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 203 - 203
  • [49] Vital staining of malignant cells in a peritoneal effusion.
    Hickling, RA
    JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1931, 34 (06): : 789 - 791
  • [50] Empiric antituberculous therapy in patients with unexplained exsudative pleural effusion.: Is it valid in Senegal?
    Sane, M.
    Ba-Fall, K.
    Lefebvre, N.
    Mounguengui, D.
    Camara, R.
    Niang, A.
    Bonnichon, A.
    Chevalier, B.
    Saliou-Mbaye, R.
    Debonne, J. -M.
    Margery, J.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2007, 63 (04) : 247 - 250